Founded in the year 1996, Dr. A Velumani, a BARC scientist turned entrepreneur, fathered Thyrocare. Thyrocare Technologies Limited has emerged to be the biggest leader and a trendsetter in the Indian Diagnostic Industry. It spans over 1000 plus dedicated service providers across India who cater to the diagnostic needs of end user and small laboratories who outsource the high-end tests to Thyrocare.
Focused on metabolic chronic disorders, Thyrocare works on intelligently packaged preventive care profiles.
Today, the rise in health calamities due to changing lifestyle has inspired the company to make preventive healthcare as its prime focus! Embracing a test menu of over 200 tests under different technologies, to detect the ever rising health issues; Thyrocare operates with a 24x7 functional Centralized Processing Laboratory (CPL) in Mumbai - India for esoteric tests; and Regional Processing Laboratory (RPL) in major metro cities of India and other parts of Asia.
The laboratory automation Aptio, a unified solution for pre-analytical, analytical and post-analytical phases, has the capacity to handle 100,000 samples every day. With an error-free processing, around Currently it handles 50,000 samples every day with over 200,000 investigations every night, before midnight and only in night. This is ably supported with its unmatched speed with a synchrony of Air cargo logistics and barcoded, bi-directional systems connecting the country to its laboratory seamlessly.
Along with technologies, automation and tests, Quality remained the heart of Thyrocare right from its inception. The laboratory got accredited by ISO 9001:2001 which has now escalated to ISO 9001:2008, NABL in 2005 and CAP (College of American Pathologists) in 2007.
Our Major Strengths
Quality, Cost, Speed, Reach, Systems and Focus
Specialties:
Thyroid, Diabetes, Anemia, Arthritis, Cancer, Infertility, Pregnancy, Preventive Healthcare, Diagnostic Laboratory, PET-CT Scan
Focused on metabolic chronic disorders, Thyrocare works on intelligently packaged preventive care profiles.
Today, the rise in health calamities due to changing lifestyle has inspired the company to make preventive healthcare as its prime focus! Embracing a test menu of over 200 tests under different technologies, to detect the ever rising health issues; Thyrocare operates with a 24x7 functional Centralized Processing Laboratory (CPL) in Mumbai - India for esoteric tests; and Regional Processing Laboratory (RPL) in major metro cities of India and other parts of Asia.
The laboratory automation Aptio, a unified solution for pre-analytical, analytical and post-analytical phases, has the capacity to handle 100,000 samples every day. With an error-free processing, around Currently it handles 50,000 samples every day with over 200,000 investigations every night, before midnight and only in night. This is ably supported with its unmatched speed with a synchrony of Air cargo logistics and barcoded, bi-directional systems connecting the country to its laboratory seamlessly.
Along with technologies, automation and tests, Quality remained the heart of Thyrocare right from its inception. The laboratory got accredited by ISO 9001:2001 which has now escalated to ISO 9001:2008, NABL in 2005 and CAP (College of American Pathologists) in 2007.
Our Major Strengths
Quality, Cost, Speed, Reach, Systems and Focus
Specialties:
Thyroid, Diabetes, Anemia, Arthritis, Cancer, Infertility, Pregnancy, Preventive Healthcare, Diagnostic Laboratory, PET-CT Scan
Location: India, Maharashtra, Navi Mumbai
Employees: 1001-5000
Phone: +91 22 3090 0000
Founded date: 1996
Investors 2
| Date | Name | Website |
| - | Norwest Ve... | nvp.com |
| - | Nalanda Ca... | nalandacap... |
Mentions in press and media 36
| Date | Title | Description |
| 25.10.2025 | PharmEasy Sells 10% Stake In Thyrocare For INR 668 Cr | SUMMARY PharmEasy’s subsidiary Docon Technologies has offloaded 53.3 Lakh equity shares or about 10% stake in listed subsidiary Thyrocare via a bulk deal The company raked in a total of INR 667.7 Cr share via the block deal, which valued ea... |
| 15.10.2025 | Q2 Results Highlights: IRFC, HDFC AMC Q2 profit rise, Axis Bank Q2 profit declines, HBD Financial, KEI Ind, Angel One, L&T finance to announce Q2 results, BoM, Persistent Systems & ICICIGI sha... | Q2 Results October 15, 2025 highlight: Find all the latest Q2 results 2025 updates of Axis Bank, Indian Railway Finance Corporation, HDFC Life Insurance Company, HDFC Asset Management Company, L&T Finance, HDB Financial Services, Oberoi... |
| 14.10.2025 | PharmEasy-Owned Thyrocare’s Q2 Profit Zooms 81% YoY To INR 48 Cr | SUMMARY On a sequential basis, the company's profit grew 25% from INR 38.3 Cr The company's operating revenue stood at INR 216.5 Cr during Q2 FY26, up 22% YoY and 12% QoQ Its total expenses rose 10% YoY and 7% QoQ to INR 157.3 Cr --> FOL... |
| 14.10.2025 | Q2 Results Highlights: BoM, Persistent Systems, ICICI Prudential & IREDA Q2 profit up, Aditya Birla Money profit declines, Tech Mahindra, ICICIGI to announce Q2 results | Q2 Results October 14, 2025 Highlights: Find all the latest Q2 results 2025 updates of Tech Mahindra, ICICI Lombard General Insurance Company, Automobile Corp of Goa, Persistent Systems, Bank of Maharashtra, Indian Renewable Energy Developm... |
| 26.09.2025 | Simple Energy Accelerates Market Dominance with $10M Bridge Round | Simple Energy secured $10M in a bridge round. Existing investors backed the electric two-wheeler firm. Funds will fuel aggressive retail expansion and R&D. The company plans 150 new stores and 200 service centers by year-end. Sales figu... |
| 25.09.2025 | Simple Energy Bags USD 10 Mn in Equity Round Led by Thyrocare Founder Simple Energy will use the fresh capital to expand retail and service networks across India, boost marketing initiatives, and allo... | Bengaluru-based EV startup Simple Energy has raised USD 10 million in an all equity funding round. The round was led by existing investor Dr. Arokiaswamy Velumani, Founder of Thyrocare's Family Office, along with fellow investors Balamuruga... |
| 25.09.2025 | Simple Energy raises $10 mn from existing investors to boost retail expansion | Bengaluru-based electric two-wheeler firm Simple Energy has raised $10 million (around Rs 88.6 crore) in an all-equity round led by existing investor Arokiaswamy Velumani, founder of Thyrocare’s family office. Other existing investors, incl... |
| 25.09.2025 | Electric two-wheeler maker Simple Energy raises $10 million from existing investors | Synopsis Simple Energy, an electric two-wheeler manufacturer preparing for its IPO, has secured $10 million in funding. This investment, led by existing investors, will fuel the company's expansion of its retail network across India, aiming... |
| 16.09.2025 | PharmEasy To Raise INR 1,700 Cr Debt | SUMMARY PharmEasy will raise fresh proceeds via NCD's by pledging the shares of its listed diagnostic company Thyrocare PharmEasy will use the fresh funds to clear the earlier debt which it raised via NCDs, with total outstanding redemption... |
| 07.08.2025 | Thyrocare CEO Rahul Guha to Lead PharmEasy as Siddharth Shah Steps Down Effective August 27, 2025, Shah will assume the position of Vice Chairman and Director at the parent company of PharmEasy and Th... | Siddharth Shah, Co-founder and current MD and CEO of API Holdings, is stepping down from his executive role later this month. Effective August 27, 2025, Shah will assume the position of Vice Chairman and Director at the parent company of Ph... |
Show more